Abstract

Lansoprazole 3-mg/mL in Ora-Blend Suspension

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2022 - Volume 26, Number 5

Page(s): 429

Download in electronic PDF format for $75

Abstract

A formulation for preparing Lansoprazole 3-mg/mL in Ora-Blend Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2022 Pg. 429	Lansoprazole 3-mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 124-128	Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Author(s): Corsini Lindsay, Williams LaVonn A
May/Jun 2010 Pg. 246	Lansoprazole 3-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 263	Erratum: Formulation: Lansoprazole 3-mg/mL Oral Suspension Author(s):
Jan/Feb 2007 Pg. 74	Lansoprazole 3-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
Jan/Feb 2025 Pg. 46	Lansoprazole 3-mg/mL Oral Suspension Author(s):
Jan/Feb 2019 Pg. 58	Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 148	Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 413	Cilazapril 1-mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 414	Clonidine 0.01-mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 496	Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions Author(s): Allen Loyd V Jr
Jul/Aug 2003 Pg. 288-291	Basics of Compounding for Raynaud's Disease Author(s): Glasnapp Andrew
Mar/Apr 2020 Pg. 140-147	The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment Author(s): Meissner Svenja, Bansal Mahima, Dela Cruz Paula Donamae, Hanning Sara, Svirskis Darren
Jan/Feb 2018 Pg. 52	Metronidazole 50 mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 314-319	Incompatibilities of Lansoprazole Injection with Other Drugs During Simulated Y-Site Coadministration Author(s): Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S
Jan/Feb 2004 Pg. 46-48	Basics of Compounding for Disorders of the External Ear Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 506	Quetiapine Fumarate 10 mg/mL in Ora-Blend Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 41-45	Formulation and Stability of Solutions Author(s): Akers Michael J